This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Jozel Frans Elisabetha Van Gestel: Innovator in Antifungal Compounds
Introduction
Jozel Frans Elisabetha Van Gestel is a notable inventor based in Vosselaar, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antifungal compounds. His work has implications for treating dermatophyte infections, showcasing his commitment to advancing medical science.
Latest Patents
Van Gestel holds a patent for "Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines." This invention concerns compounds that are used as medicine, characterized by a specific formula that includes various substituents. The compounds are designed to be effective against dermatophytes, and the patent details their preparation and potential applications in medical treatments.
Career Highlights
He is currently associated with Janssen Pharmaceutica NV, a prominent company in the pharmaceutical industry. His role at Janssen has allowed him to work on innovative solutions that address critical health issues. With a focus on antifungal treatments, Van Gestel's contributions are vital in the ongoing battle against fungal infections.
Collaborations
Throughout his career, Van Gestel has collaborated with esteemed colleagues such as Terence Gilkerson and Roger John Nash. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical sector.
Conclusion
Jozel Frans Elisabetha Van Gestel is a distinguished inventor whose work in antifungal compounds has the potential to make a significant impact on medical treatments. His dedication to innovation and collaboration in the pharmaceutical industry exemplifies the importance of research in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
